XML 27 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY - USD ($)
$ in Millions
Total
Convertible preferred stock
Class A and Class B common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income (loss)
Preferred shares outstanding, beginning of the period (in shares) at Dec. 31, 2020   0        
Shareholders equity, beginning balance at Dec. 31, 2020 $ 333.8 $ 0.0 $ 0.0 $ 2,564.3 $ (2,241.4) $ 10.9
Shares outstanding, beginning of the period (in shares) at Dec. 31, 2020     405,700,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Release of restricted stock units and awards (in shares)     14,800,000      
Shares withheld related to net share settlement of restricted stock units and awards (in shares) (5,100,000)   (4,600,000)      
Shares withheld related to net share settlement of restricted stock units and awards $ (124.8)     (35.2) (89.6)  
Repurchases of common stock (in shares)     (41,100,000)      
Repurchases of common stock $ (1,058.5)     (314.3) (744.2)  
Exercise of stock options and awards (in shares) 100,000   700,000      
Exercise of stock options and awards $ 6.9     6.9    
Assumed stock options in connection with acquisition 1.2     1.2    
Purchase of bond hedges in connection with issuance of convertible senior notes (265.3)     (265.3)    
Sale of warrants in connection with issuance of convertible senior notes 202.9     202.9    
Tax benefit attributable to bond hedges purchased in connection with issuance of convertible senior notes 0.5     0.5    
Stock-based compensation 287.1     287.1    
Other comprehensive loss (13.5)         (13.5)
Net income 335.8       335.8  
Preferred shares outstanding, end of the period (in shares) at Dec. 31, 2021   0        
Shareholders equity, ending balance at Dec. 31, 2021 (293.9) $ 0.0 $ 0.0 2,448.1 (2,739.4) (2.6)
Shares outstanding, end of the period (in shares) at Dec. 31, 2021     375,500,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Release of restricted stock units and awards (in shares)     14,400,000      
Shares withheld related to net share settlement of restricted stock units and awards (in shares)     (5,100,000)      
Shares withheld related to net share settlement of restricted stock units and awards (119.4)     (41.5) (77.9)  
Repurchases of common stock (in shares)     (35,600,000)      
Repurchases of common stock (795.4)     (287.4) (508.0)  
Exercise of stock options and awards (in shares)     200,000      
Exercise of stock options and awards 0.5     0.5    
Tax benefit attributable to bond hedges purchased in connection with issuance of convertible senior notes 61.2     61.2    
Stock-based compensation 330.7     330.7    
Other comprehensive loss (46.3)         (46.3)
Net income $ 553.2       553.2  
Preferred shares outstanding, end of the period (in shares) at Dec. 31, 2022 0 0        
Shareholders equity, ending balance at Dec. 31, 2022 $ (309.4) $ 0.0 $ 0.0 2,511.6 (2,772.1) (48.9)
Shares outstanding, end of the period (in shares) at Dec. 31, 2022     349,400,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Release of restricted stock units and awards (in shares)     15,100,000      
Shares withheld related to net share settlement of restricted stock units and awards (in shares) (5,300,000)   (5,300,000)      
Shares withheld related to net share settlement of restricted stock units and awards $ (135.1)     (48.5) (86.6)  
Repurchases of common stock (in shares)     (22,700,000)      
Repurchases of common stock $ (542.8)     (205.6) (337.2)  
Exercise of stock options and awards (in shares) 200,000   200,000      
Exercise of stock options and awards $ 2.5     2.5    
Stock-based compensation 338.0     338.0    
Other comprehensive loss 27.4         27.4
Net income $ 453.6       453.6  
Preferred shares outstanding, end of the period (in shares) at Dec. 31, 2023 0 0        
Shareholders equity, ending balance at Dec. 31, 2023 $ (165.8) $ 0.0 $ 0.0 $ 2,598.0 $ (2,742.3) $ (21.5)
Shares outstanding, end of the period (in shares) at Dec. 31, 2023     336,700,000